Science Explorer Back to mapMap
Discussion
Institution · Meda (Germany)

Most cited papers from Meda (Germany)

Meda (Germany)

What are the most cited papers from Meda (Germany)?

The most cited paper from Meda (Germany) is "Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy" (Dan Ziegler, Ametov As, Alexey N. Barinov et al., 2006), with 560 citations. Next come "Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy" (398) and "A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis" (243).

Showing 50 of 51 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy Dan Ziegler, Ametov As, Alexey N. Barinov et al. · Diabetes Care Open access 25 Oct 2006 560
2 Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy Dan Ziegler, Phillip A. Low, William J. Litchy et al. · Diabetes Care Open access 21 Jul 2011 398
3 A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis Warner Carr, Jonathan A. Bernstein, Phil Lieberman et al. · Journal of Allergy and Clinical Immunology 12 Mar 2012 243
4 Safety and Efficacy of Pimecrolimus in Atopic Dermatitis: A 5-Year Randomized Trial Bárður Sigurgeirsson, Andrzej Boznański, Gail Todd et al. · PEDIATRICS 24 Mar 2015 150
5 Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis Eli O. Meltzer, Paul H. Ratner, Claus Bachert et al. · International Archives of Allergy and Immunology Open access 2013 118
6 Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4years in the NATHAN 1 trial Dan Ziegler, Phillip A. Low, Roy L. Freeman et al. · Journal of Diabetes and its Complications 10 Nov 2015 79
7 Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis William E. Berger, Shailen R. Shah, Phil Lieberman et al. · The Journal of Allergy and Clinical Immunology In Practice 2 Jan 2014 60
8 Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances Margitta Worm, DucTung Nguyen, Russ Rackley et al. · Clinical and Translational Allergy Open access 9 Jun 2020 42
9 Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29‐02, a novel aqueous nasal spray Hartmut Derendorf, Ullrich Munzel, Ursula Petzold et al. · British Journal of Clinical Pharmacology Open access 22 Feb 2012 36
10 Microphysiological testing for chemosensitivity of living tumor cells with multiparametric microsensor chips Angela M. Otto, Martin Brischwein, Axel Niendorf et al. · Cancer Detection and Prevention 2003 33
11 Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study Philippe Saïag, Artur Bauhofer, Fabrice Bouscarat et al. · British Journal of Dermatology 11 Apr 2009 33
12 Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms Robert B. Hermann, Julius Mungo, Peter Jürgen Cnota et al. · Clinical Pharmacology Advances and Applications Open access Nov 2014 29
13 Validation of a Modified 28-Day Rat Study to Evidence Effects of Test Compounds on the Immune System H.‐B. Richter‐Reichhelm, Clemens Dasenbrock, G�rard Descotes et al. · Regulatory Toxicology and Pharmacology Aug 1995 25
14 Nonparametric non‐inferiority analyses in the three‐arm design with active control and placebo Ullrich Munzel · Statistics in Medicine 18 Sep 2009 20
15 Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers Jordi Roca‐Ferrer, Laura Pujols, María Pérez et al. · Allergy Asthma and Clinical Immunology Open access Dec 2018 16
16 Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma Kai R. Richter, Lars Grönke, Stanislawa Janicki et al. · Pulmonary Pharmacology & Therapeutics Open access 7 Dec 2006 13
17 Peak Inspiratory Flow Rates Generated through The Novolizer ® And The Turbuhaler ® Dry Powder Inhaler Devices by Children with Stable Asthma Andrea v. Berg, Hans-Joachim Kremer, Barbara Ellers‐Lenz et al. · Journal of Aerosol Medicine Mar 2007 12
18 The Impact of Vehicle Front End Design on AC Performance Ken T. Lan, Ling Xiao, Kumar Srinivasan et al. · SAE technical papers on CD-ROM/SAE technical paper series Conference paper 8 Apr 2013 9
19 Real‐life effectiveness of a new allergic rhinitis therapy (MP29‐02*) in Sweden Pär Stjärne, Victoria Strand, Kaj Theman et al. · Clinical and Translational Allergy Open access 26 Jun 2015 8
20 Short and long‐term safety of MP29‐02*: a new therapy for the treatment of allergic rhinitis David Price, Jean Bousquet, Peter William Hellings et al. · Clinical and Translational Allergy Open access 16 Jul 2013 6
21 Varicose vein surgery after acute isolated superficial vein thrombosis in daily practice: INSIGHTS-SVT study T. Noppeney et al. · Journal of Vascular Surgery Venous and Lymphatic Disorders Open access 29 May 2024 5
22 4th Pediatric Allergy and Asthma Meeting (PAAM) the Bilastine Pediatric Safety Study Group et al. · Clinical and Translational Allergy Open access908 authors Nov 2016 5
23 Single-Dose Pharmacokinetics and Safety Pharmacodynamics of Formoterol Delivered by Two Different Dry Powder Inhalers Ursula Petzold, Hans-Joachim Kremer, Duc Tung Nguyen et al. · Journal of Aerosol Medicine and Pulmonary Drug Delivery Open access 3 Jul 2008 5
24 A randomized, double‐blinded, placebo‐controlled study to evaluate the efficacy and safety of venlafaxine extended release in Japanese patients with generalized anxiety disorder Tempei Otsubo, Koichiro Watanabe, Takeshi Inoue et al. · Psychiatry and Clinical Neurosciences Open access 22 Oct 2025 4
25 Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa Sònia Vicens‐Artés, Jordi Roca‐Ferrer, Valeria Tubita et al. · Clinical & Experimental Allergy Open access 23 Jan 2022 4
26 ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis Heidrun Lingner, Anika Großhennig, Kathrin Flunkert et al. · JMIR Research Protocols Open access 4 Dec 2015 4
27 Synergistic Bronchodilatory Effects of Dexpirronium and Formoterol in Guinea Pigs Artur Bauhofer, Joachim Maus, Ursula Petzold et al. · Journal of Allergy and Clinical Immunology Feb 2008 2
28 A new allergic rhinitis therapy (MP29‐02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch Wytske Johanna Fokkens, Peter William Hellings, Joaquim Mullol et al. · Clinical and Translational Allergy Open access 26 Jun 2015 2
29 Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from randomized controlled trials Robert B. Hermann, Peter Cnota, Joachim Maus · British Journal of Clinical Pharmacology Open access 13 Jan 2012 2
30 A prospective, multicenter, real-world effectiveness and safety study of high molecular weight sodium hyaluronate for interstitial cystitis/bladder pain syndrome Robert Stoica, Jose Medina-Polo, Rustom Pervez Manecksha et al. · International Urology and Nephrology Open access 5 Feb 2026 1
31 Pain and Health Related Quality of Life in Patients with Superficial Vein Thrombosis: A Post Hoc Analysis of the Multicentre INSIGHTS-SVT Study Rupert Martin Bauersachs, Ulrich Hoffmann, David Pittrow et al. · European Journal of Vascular and Endovascular Surgery Open access 6 Nov 2025 1
32 Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Azelastine Hydrochloride in Children with Perennial Allergic Rhinitis Jean Bousquet, Ludger Klimek, Hans-Christian Kuhl et al. · International Archives of Allergy and Immunology Open access 6 Dec 2024 1
33 1D Modeling of HVAC Unit Air Flow for Automatic Climate Control Simulations Yasaman Masoudi, Shankar Natarajan · SAE technical papers on CD-ROM/SAE technical paper series Conference paper 6 Apr 2021 1
34 Health-care costs of asthma are lower using mp29-02* vs. Sequential sprays for allergic rhinitis Brooke S. Harrow, Ahmad R. Sedaghat, Ullrich Munzel et al. · Value in Health Open access May 2015 1
35 A new intranasal therapy (MP29‐02*) is more effective than current firstline therapy regardless of season, symptom or severity. Claus Bachert, Wytske Johanna Fokkens, Peter William Hellings et al. · Clinical and Translational Allergy Open access 26 Jun 2015 1
36 MP29‐02*’s advanced delivery system contributes to its efficacy in patients with moderate/severe seasonal allergic rhinitis Glenis Kathleen Scadding, Claus Bachert, Peter William Hellings et al. · Clinical and Translational Allergy Open access 26 Jun 2015 1
37 A new allergic rhinitis therapy (MP29‐02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies Peter William Hellings, Claus Bachert, Ralph Mösges et al. · Clinical and Translational Allergy Open access 26 Jun 2015 1
38 An open‐label, long‐term extension, multicenter study to evaluate the safety and efficacy of venlafaxine extended release in Japanese outpatients with generalized anxiety disorder Tempei OTSUBO, Koichiro Watanabe, Takeshi Inoue et al. · Psychiatry and Clinical Neurosciences Reports Open access 6 Jul 2026 0
39 Identifikasi Tingkat Kecenderungan Perilaku Adiktif Mahasiswa Generasi Z Erwita Ika Violina, Rafael Lisinus Ginting, Fadinda Aisyah et al. · PSIKOLOGI KONSELING Open access 7 Jan 2026 0
40 Effectiveness of silymarin with lifestyle intervention in NAFLD and metabolic syndrome: a prospective single-arm study Wattana Sukeepaisarnjaroen, Roongruedee Chaiteerakij, Elvie Victonette Gonzalez et al. · Drugs in Context Open access 6 Apr 2026 0
41 Response to “Clinical relevance of venlafaxine ER for generalized anxiety disorder” Tempei Otsubo, Koichiro Watanabe, Takeshi Inoue et al. · Psychiatry and Clinical Neurosciences Open access 26 Jan 2026 0
42 A Novel Co-Simulation Framework for Optimizing Human Thermal Comfort and Energy Consumption in a Vehicle Shankar Natarajan, Sudharsan Balasubramanian · SAE technical papers on CD-ROM/SAE technical paper series Conference paper 31 Mar 2025 0
43 Efficacy of Tolcapon on Parkinson's Disease Associated Non Motor Symptoms: The TANIMOS Study (P01.066) Thomas H. Müller, Martina Witzer, TANIMOS Study Group · Neurology 12 Feb 2013 0
44 [Sport mentors for persons with Down Syndrome sought]. Christine Landschneider · PubMed Dec 2012 0
45 Budget Impact Model of Ceplene® As Maintenance Therapy in Adult Patients with Acute Myeloid Leukemia in First Remission Lisette Kaskens, D. Gehenio, Ullrich Munzel et al. · Value in Health Open access 26 Oct 2014 0
46 A new therapy (MP29‐02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity Glenis Kathleen Scadding, David Price, Jean Bousquet et al. · Clinical and Translational Allergy Open access 16 Jul 2013 0
47 A new therapy (MP29‐02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion Claus Bachert, David Price, Glenis Kathleen Scadding et al. · Clinical and Translational Allergy Open access 16 Jul 2013 0
48 PD15 ‐ MP29‐02 effectively relieves both nasal and ocular symptoms in adolescents aged 12‐17 years: results from a meta‐analysis of 4 randomised controlled Seasonal Allergic Rhinitis (SAR) trials Erkka Juhani Valovirta, Ruth Murray, Ullrich Munzel et al. · Clinical and Translational Allergy Open access 28 Feb 2014 0
49 A new therapy (MP29‐02*) provides effective relief from all individual nasal and ocular symptoms of seasonal allergic rhinitis Peter William Hellings, Claus Bachert, Jean Bousquet et al. · Clinical and Translational Allergy Open access 16 Jul 2013 0
50 A new efficacy parameter (complete/near complete symptom relief) in allergic rhinitis management: results with a new therapy MP29‐02* Jean Bousquet, Glenis Kathleen Scadding, David Price et al. · Clinical and Translational Allergy Open access 16 Jul 2013 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.